Delivery Order SPE2DB24D2205-SPE2DB25FDWND

Award Date 1/6/25
Potential Completion Date 1/7/25
Potential Value $34K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,566,185,950 units of Menopur 75 unit vials to the Defense Logistics Agency (DLA) under a $17,371.65 firm-fixed price delivery order. The prime contractor is AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 24, 2024 and was awarded on October 23, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of 4,565,058,855 units of MENOPUR 75 drug vials to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on a firm-fixed-price basis with a ceiling value of $73,941.66 and a completion date of July 3, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,574.28 firm-fixed-price delivery order is for the supply of 4,559,220,764 units of Menopur 75 unit vials. The contract has an ultimate completion date of December 1, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,852.88 firm fixed-price delivery order is for the supply of 4,566,759,012 units of the medication Menopur, a 75-unit vial. The contract has an ultimate completion date of December 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,560,664,991 units of the pharmaceutical product Menopur 75 unit vials. The fixed-price delivery order, valued at $75,195.60, has an ultimate completion date of April 21, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MENOPUR 75 unit vials. The contract, valued at $154,288.28, has an ultimate completion date of October 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026....
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of MENOPUR 75 UNIT VIALS medical supplies. The contract has a ceiling value of $16,545.12 and an ultimate completion date of April 26, 2024. The contract is a Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA), which is the primary logistics and supply agency for the U.S. Department of Defense (DoD). Amerisourcebergen holds a $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,992.54 firm fixed-price delivery order is for the supply of 4,566,667,712 units of the drug Menopur, a medication used in fertility treatments. The contract has an ultimate completion date of December 11, 2024 and was awarded on December 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,558.64 firm fixed-price delivery order is for 4566749515 MENOPUR 75 UNIT VIALS, with a completion date of December 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $75,004.13 firm fixed-price delivery order is for the supply of MENOPUR 75 unit vials, with a period of performance through May 3, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDWND
    Delivery Order

This federal contract award is for the delivery of Menopur 75 unit vials to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $34,197.40, is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 7, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/7/25, 10:47 AM